A Study of LY3209590 in Participants With Type 2 Diabetes

Clinical trial NCT03367377 · COMPLETED

Trial details

NCT number: NCT03367377
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2018-01-03
Primary completion: 2018-10-03
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.